CORETECH 5 |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 EUR | -62.50% |
|
-62.50% | +500.00% |
| 2023 | Gour Medical SA announced that it has received €0.135 million in funding | CI |
| 2023 | Gour Medical SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2021 | 0 0 0.07 | Sales 2022 | 0 0 0 | Capitalization | 133K 124K 11.1M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 0 | Net income 2022 | - 0 0 | EV / Sales 2021 | 1,19,68,60,759 x |
| Net Debt 2021 | 814K 756K 67.9M | Net Debt 2022 | 23.49K 21.81K 1.96M | EV / Sales 2022 | 1,56,52,10,00,000 x |
| P/E ratio 2021 |
-1.38
x | P/E ratio 2022 |
-9.55
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -62.50% | ||
| 1 week | -62.50% | ||
| Current month | -62.50% | ||
| 1 month | -57.14% | ||
| 3 months | -57.14% | ||
| 6 months | +50.00% | ||
| Current year | +500.00% |
1 week
0.03
0.08
1 month
0.030.08
Current year
0.010.08
1 year
0.010.08
3 years
0.010.12
5 years
0.011.41
10 years
0.0110.57
| Managers | Title | Age | Since |
|---|---|---|---|
Serge Goldner
CEO | Chief Executive Officer | 59 | 14/14/14 |
Eva Bleul
LAW | General Counsel | - | - |
| Sales & Marketing | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 01/19/01 |
| Director/Board Member | 65 | - | |
Serge Goldner
CEO | Chief Executive Officer | 59 | 14/14/14 |
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.03 | -62.50% |
| 02/24/02 | 0.08 | 0.00% |
| 30/24/30 | 0.08 | 0.00% |
| 29/24/29 | 0.08 | 0.00% |
Real-time Euronext Paris, May 03, 2024 at 03:00 pm IST
More quotes
Coretech 5 (formerly Gour Medical) specializes in the development and commercialization of innovative veterinary solutions for the management of the main pathologies of companion animals. Its unique positioning is based in particular on the use of natural products based on hemp extracts. Devoid of psychoactive effects, WEEDLEY, its first range of premium solutions, increases the effectiveness of cannabidiol thanks to the surround effect.
Sector
-
- Stock Market
- Equities
- MLCOT Stock